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Susan Ball , M.D.. Chief Resident: Mr. B, a thirty-five-yea r-old white male , was admitted to the medical
service with chief com plaints of fever, chills, an d increasi ng shortness of breath. Thi s was Mr. B's second
admission. His first was six month s ago for pneumonia, leukopen ia , and lymphadenopathy of unkno wn
etio logy. At tha t time he was treated with antibiotics ; he improved and was discharged. Since that time Mr .
B reported continuing to feel weak and leth ar gic. Two weeks before th is admission he noted the onset of
fever , ch ills, sore throat, and a nonproductive cough. He initi ally sa w a medica l doctor for these comp lain ts
who diagnosed his problem as bronch itis and treated him with intra muscu lar injections that were probabl y
antibiotic in nature. He continued to experience malaise and fever. Next he saw an otolaryngologist, who
diagnosed Mr . B as having oral th rush. He was placed on Mycostatin Ora l Suspensions , but cont inued to
experience increasi ng fever, chills, shortness of brea th, and sore th roat, as well as a rthra lgias, abdominal
pa in, and diar rhea. Shortly thereafter Mr. B was admitte d to the hospita l.
Mr . B's past medica l history is remarkabl e for anemia and a hiatal hern ia . Famil y history is remark ab le
for myocard ial infarct ion and ca rcinoma. Social history revealed that the patien t was an educa tor who
den ied tobacco use, admitted to occas iona l alcohol use, and denied any ora l or intravenous drug abuse. He
had been living with the sa me man for the past twelve years, but had had sexual partners outside the
relationship up unt il a yea r prior to admission.
On physical exa minat ion Mr . B was a well developed Hispan ic ma le who appea red acutely ill. He was in
mild respira tory distress and was diaph oret ic. Temperature was 103.5°. Pulse was 125 per minute.
Respirations were th irt y-six per minute. His blood pressur e was 130/80. Physical examin at ion was
remarkabl e for a white exud ate on the posteri or phar ynx and white plaques on the roof of his mouth . Th e
neck was supple without lymph aden opathy. Th e lungs displayed decreased breath sounds to auscultation
with dullness to percussion at both bases; there were also ra les bilaterally on auscultation. Mr . B's physical
examina tion was otherwise unremarkable.
Pertinent laboratory studies included a complete blood count that showed a white count of 7.5 K/ CUM ,
with 70 segs, 15 lymph ocytes, one aty pica l lymphocyte, four monocyte s, four eosinophils, and six stabs.
Hemoglob in was 12.8 G/D L. Th ere was I + anisocytosis. Arteria l blood gases showed a pH of 7.52, a p02of
55 mm Hg, a pC02 of 33 mm Hg, and 92% O2 satura tion. On four lite rs of oxygen by nasal canul a the
pat ient' s p02went up to 106 mm Hg. Chest X-R ay revealed bibasilar inte rstitia l disease and blunt ing of the
costophrenic angles, with a possible sma ll pleur al effusion.
Mr . B was seen by Hematology, Infectio us Diseases, and Otol arygology. He underwent transbronchial
biopsy which revealed Pneumocystis carinii. He was sta rted on Bactrime and a provisional diag nosis of
Acquired Immune Deficiency Syndrome (A IDS ) was mad e. Hematology, who had seen the pat ient on his
previous admission, found that he had diminished OKT4 and OKT8 ratios. Following that the diagnosis of
A IDS was felt to be well establ ished.
Mr . B had persistent nau sea and anorexia in the hospit al which was felt to be caused by pancrea titis
that may have been a side effect of Bactrime, His amylase level at one point was as high as 463 Somogyi
unit s/ 100 ml. Mr . B's pancreatitis was treated symptomatica lly. By the time of discha rge this problem had
resolved.
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with ARC who have existing immunological abnorma lities do not change, that is to say, they do not appear to
get better or get worse. We do not know what will happen over the long run , ten or fiftee n years.
As of October I, 1984, the CDC reported that the numb er of cases of AIDS cont inues to double every
six month s. As of November 6, 1984, the number of cases was 6,993. We are now undoubtedly over 7,000.
The distribution of AIDS is as follows. California and New York are reportin g the highest number of cases.
Texas, Florida, and New Jer sey are the second tier of states, reporting the next highest incidence of AIDS. In
the third tier of sta tes are Pennsylvania, Ohio, Michigan, Indiana, Iowa, Arkansas, Virginia, Georgia ,
Louisiana, Colorado, Ari zona, and Washington. A common denominator for these sta tes is the presence of a
large metr opolitan area, where the great est number of cases occur.
Roughl y thr ee-quarters of pat ients (a bout 72%) with AIDS are homosexual or bisexual men (in the
United St ate s, not necessaril y in oth er parts of the world). Roughly seventeen percent are parenteral drug
abusers. Roughl y four percent are of Haiti an origin . One may argue that there is a significant area of overlap
betwee n these grou ps. The epidemiological data that is accumulating on the human T-Ieukemia virus III
(HTLV-III) suggests that it is important to recognize that some ethni c groups, because of their origin, may
be at greater risk than others. One percent of AIDS cases nati onwide occur in hemophiliacs; the incidence in
pat ients with hemophili a is much higher than in other risk groups. Pat ients who are heterosexual contacts of
members of other known risk groups repre sent one percen t of those with AIDS. Tr ansfusion related cases
account for one percent of all cases. Unknown or other are four percent of the total; th is four percent includes
pediatric patients, some who died before appropria te interviews and investigat ions could be carried out, and
some for whom no risk characteristics are known.
Over a third (37%) of all cases of AIDS are reported to occur in New York City. San Francisco report s
twelve percent , Los Angeles eight percent , Miami four percent , and Newark three percent. These are figures
valid through October I, 1984. AIDS is primaril y a disease of urban areas and their surro unding counties at
this time.
With regard to case present at ion, those pat ients who present with Kaposi's sarcoma instead of an
opportunistic infect ion seem to have a somewhat better prognosis. Th is presenta tion is more common in those
patients in the large st risk group, men who are homosexually or bisexually active.
There are no great surprises in the breakdown of racial and ethn ic stat istics, except that in a few cities
there is a disproportionate percentage of AIDS in Blacks. These cities include Philadelphia, Washington,
and Baltimore. This may have to do with the epidemiol ogy in different populati ons in different urban
areas.
Female pat ients with AIDS are primaril y members of the intr avenous dru g abuse risk group, or have
cont act s with bisexually active men or intravenous drug abusers.
Again, there is frequentl y an overlap between risk groups. The CDC catagorizes these patients by their
major life style risk, e.g., the y are predominatel y drug abusers with litt le homosexual contact or
predominately homosexually active men who infrequently abu se drug s.
AIDS is a venereal disease which is transmitted by sexual contact. Like many venerea l diseases, it may
be transmitted by the parenteral route as well. Parenteral drug abuse, transfusion of conta minated blood
products, and blood contamination of body secreti ons at the time of intim ate contact may all be responsible
for the spread of AIDS.
There is a small group of patients with AIDS who do not appear to belong to any of the major risks
groups, that is to say, the y are not male homosexuals and bisexuals, intravenous drug abusers, hemophiliacs,
or Ha itian s. In that group a significa nt portion are actually sexual contac ts of members of major risk groups.
Some of them are the child ren of mothers who are members of risk groups; a few of them are children whose
mothers appear to be normal, but whose fathers are members of risk groups.
The older a case of AIDS is in terms of the date of diagnosis the more likely it is that the patient will
have expired . Ultimately we believe that AIDS will probably be an entirel y fatal disease. Patients present ing
with an opportu nistic infection, such as P. carinii pneumonia, are usually dead with in one year of their
diagnosis. The patients who live longest are those who present with Kaposi's sarcoma and do not develop an
opportunistic infection, at least not earl y in their course.
In Philadelphia the number of cases of AIDS cont inues to double each quarter. Looking at nat ional
statistics, one sees a similarly alarming rise in cases being reported around the country. In New York sta te
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half of the reported cases come from New York Cit y. Th is is an exa mple of AIDS as primar ily an urban
disease (likewise in California, where two-thirds of all reported cases come from San Francisco).
As of Jul y 1984, there have been 421 reported foreign cases of AIDS. The se reports a re the result of
passive surveillance in most foreign countries. The majority of foreign cases being report ed come from
Eur ope because they probabl y recognize more cases. AIDS is probab ly, however, a worldw ide disease.
The primar y pulmonar y infections in patients with AIDS are P. carinii pneum onia, pulmonary
cytomega lovirus infecti ons, and pulmon ar y M. aviumintracellulare infectio ns. Mucosal infect ions are very
debilitating to the patient. They are difficult to cont rol, make the pat ient's life miserable, and may inte rfere
with his nutritional status. An example is severe perianal herpetic disease, somet hing that is a serious
medical problem and make s the patient extremely uncomfor table.
Centra l nervous system infections in patients with AIDS a re freque nt ly fat al. The y include toxoplasmo-
sis, cryptococcal mening itis, progressive multi focal leukoence phalitis, cytomegalovirus encephalitis, and
centra l nervous system aspergillosis.
Cryptosporidiosis and giardias is a re common gastrointest inal infections in pati ents with AIDS which
may cause severe diarrhea and malabsorption. We can treat the giardiasis, but it is very di fficult to
effect ively treat the cryptosporidi osis. Long term par ent eral hyperal imentation is sometimes requ ired
because of the severity of the malabsorpt ion.
Chorioret initis in pat ients with A IDS is usually a resu lt of a cytomega lovirus infection , a lthough
occasio nally other entities may cause this problem as well. Often th is will leave the pat ient blind.
Malign anci es which are not recognized to produce systemic immunosuppression, but are considered to
result from the immunosuppression that occurs in AI DS are Kaposi's sarcoma and CNS Iymphoma- a very
rar e entity. The present a tion of Kaposi's sarcoma can be very varia ble; lesions can be both visceral and
cuta neous, unl ike the usual present at ion of Kaposi's sarco ma occurring in the otherwise older healthy male
as cutaneous lower ext remity lesions. Typical lesions may occur on the heel, chest, pa late, or in the
gas trointes tina l tract.
Other malign anc ies are probably also occurring with increasing frequ ency, at least in the homosexual
and bisexual populati on. Whether or not th is is trul y relat ed to AIDS remai ns unclear. We cannot presently
diagn ose AIDS in a pat ient with syste mic lymph oma, which produces its own immunosuppression.
Rather poorly effect ive therap y is avai lable for patients with M. avium infect ions, cryptosporidiosis
infections, and Kaposi's sa rcoma. We have no therapy presently for pat ients with progressive multifocal
leukoencephalopa thy, idiopathic encephalopathy, cytomegalo virus infections, Epstein-Barr virus infections,
or the renal insufficiency that occurs in five to ten percent of AIDS patients. We can treat th ings like
cryptococcal meningitis, but patients tend to relapse as soon as therapy is stopped. We can trea t P. carinii
infecti ons, but aga in, patients tend to relapse. Also, the treatments themselves often have serious
complications, such as the leukopenia that may result from Bactrimw.
AIDS is a venereal and blood borne disease. It can be spread by sexual contac t, as well as by contact
with blood products. Wh eth er other secretions can transmit the disease is unclear at this time . In patients
with AIDS Relat ed Complex, the HTLV-III virus has been found in sal iva and in semen.
Recommendations are that pat ients who are memb ers of known risk groups should not donat e blood.
They should be very circumspect about sexual contact with others. If they have AIDS, they should not have
sexua l contact or at least should explain to their partner that they have AIDS. Even if an an tibody assay for
HTLV is put into use, this will not with one hundred percent efficiency guarantee the safe ty of the blood
from a transmitt able agent. For this reaso n, we are going to continue to recommend for some time that
memb ers of known risk groups do not donate blood regard less of the avai lability of an antibody assay .
Isolat ion in the hospital of pati ent s with AIDS is directed aga inst the known means of tra nsmission.
Because it is a blood borne disease, patients have to be on blood and body fluid precau tions. In thi s hospital,
becau se we still use enteric precaut ions for patients with hepati tis, we also use it for pat ients with AIDS. The
major ity of patients with AIDS do have symptomat ic diarrhea. Private rooms are needed only for patients
who do have prob lems with the ir enteric secret ions. In man y hospitals enteric precau tions are not routinely
used.
Any contact with the blood or bodily secretions of a pati ent with AIDS is potenti a lly hazard ous.
Materials that have been contaminated need to be sterilized or disposed of properly. With the appropriate
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precauti ons, as is outlined in the hospit al isolation manu al, it is perfectly safe to perform an y necessary
diagn ost ic or therapeutic procedure on th ese pat ients. Th e major logistical problem is that if you have to do
hemod ialysis then that machine should be used only on pat ients with AIDS.
HTLV-III , a retro virus, a member of a large fam ily of viruses, is though t to be on fairl y good (but not
absolute) evidence at this time to be the probabl e causa tive agent in AIDS. Unlike HT LV-I, which has been
found in a small number of pat ients with AIDS and AIDS Related Com plex, this virus has been isolated
from th irt y to fifty percent of patients with AIDS and some pat ients with AIDS Related Complex. Antibody
evidence of infection with this virus has been found in ninety-one percent of patients with AID S and
ninet y-eight percent of patients with AIDS Related Comp lex. Abo ut fifty percent of a populat ion of
hemoph iliacs screened gave evidence of similar exposure . Between fifty to eighty percent of pat ients who
were healthl y and homosexually or bisexually activ e have been found to have antibodies to th is agent. It has
a lso been found in mothers of bab ies with AIDS, the babie s themselves, and mem bers of high risk groups
whose blood is known to have caused AIDS. Oth er so called low risk gro ups have been antibody negat ive to
dat e.
HTLV-III is a lymph otr opic virus th at preferentially infects T4 cells. It is the loss of T4 cells tha t is
lar gely felt to be responsible for the immun ologic defect in pat ients with A IDS. Interestingly, this is a virus
that prefers to infect activated T-cells ra ther than nonactivated T-cells. This is probably of some importa nce
because the lifestyle of homosexually and bisexually active males may make them more immunologically
activated. Sim ilarly, hemophiliac patients may also be immunologically tu rned on.
In foreig n countries, particularly in the Ca ribbean nation s and Centra l Africa, it has been noted that
fewer of the patients recognized appear to be mem bers of known risk groups in the U.S. If you exami ne those
patients who do not appear to be members of known risk groups, a large numb er are heterosexually, as well
as homosexuall y, promiscu ous. There does appea r to be a correla tion between multiple sexual partners in
those patients and the likelihood of developing AIDS. In a sma ll population studied in Centra l Afr ica, ther e
was a high incidence of HTLV-III antibody in the group of prostitutes stu died. Those patients who
themselves are not promiscuou s who develop AIDS are frequentl y the contact of sexua lly promiscuous
persons.
If HTLV-III virus is the cause of AIDS, then we are developing assays that can predict prior exposure
to the virus. We don't know exac tly what exposure to the HTLV-III virus mean s a t this time . Man y people
who have evidence of exposure to th is virus are health y; the y are not even minimally symptomat ic. Some of
the se people will probably never develop disease. Some may develop illness later. Som e patients who develop
mild symptoms may not progress to more serious disease. So at this time we don't know how to use an
antibody assay of HTLV-III virus except to screen potential blood donors. Again , the use of the assay in this
way will be help ful, but does not guar antee one hundred percent protect ion agai nst the transmittab le agent.
Knowing the virus may eventu ally enable us to develop a vaccine, but I suspect that progre ss in th is area
will be much slower th an initia lly predicted. We don't know that a killed virus vaccine will be protect ive, and
I don't think that anyone will want to take a chance on a live attenua ted virus vaccine at th is time. Dr.
Hauptman, would you comment on this case, please?
S tephen Hauptman. D.G.. Professor of Medicine. Cardeza Foundation: Th ere are two points that I would
like to make. First , it has recentl y been proposed that HTLV-III , a retrovirus, is the cau se of AIDS. A
retrovirus is an RNA virus, one that has in its genome a gene tha t controls a protein tha t we call reverse
transcriptase. The virus infects the cell, making its own reverse transcriptase. It then takes nucleotides from
the host cell and makes its own copy of DNA. Th is copy is frequent ly, but not always, incorpo rated into the
DNA of the host. It may be integrat ed in one spot or a number of spots. In the case of AIDS and HT LV-II I,
it would appear to be integrated into a number of spots.
What put investigators onto the study of retrovirus is a disease called feline leukemia, which is also due
to a retrovirus and produces eit her a leukemic syndrome or an immunodeficiency syndro me- ma nifested by
opportunistic infections. Secondly, HTLV-I has been highly associated with an adult T-cell leukemia that is
not found in this count ry. In the United St ate s most adult T-cell leukemi as are not associated with HT LV-1.
Patients with HTLV-I associated adult T-cell leukemia, much like feline leukemia, frequently have
opportunistic infections.
Last year there was a published report of HTLV-I having been isolated in a small number of patie nts
with AIDS (I). Simultaneousl y, there was another report that a significant percentage of patients with
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AIDS had antibodies to the HTLV-I virus (2) . At the time it was felt that HTLV-I migh t be the cause of
AIDS. As time went on, it was found th at an increasingly small er number of AI DS patients had the HTLV-I
virus. Now we know that the anti body to HTLV-III happens to cross-reaction to HTLV-I. So, one thing we
know for sure is that HTLV-I is not the cause of AIDS. Th ese patients, by the way, have lots of viruses that
can be isolate d.
Subsequentl y, the HTLV-III virus was isolated in eighty-five percent of patients with AIDS and
seventy-five to eight y percent of pat ients with the associa ted lymph node enlargement syndrome (3) . As an
aside, the lymph node enla rgement syndrome associa ted with AIDS is frequently called Pre-AIDS. I don' t
like this name because only a sma ll portion with lymph node enlarge ment or wasting syndromes will act ually
go on to develop AIDS. In fact , only three or four percent of these patients will develop AIDS (4) .
To show that HTLV-I II infects a cell, you have to do somet hing unusual. You have to acti vate the cell
with a mitogen . Th at was the stumbling block that kept researche rs from discover ing this possible ca use of
AIDS sooner. First, you would take T-cells, activa te them with PH A, add a growth factor, and then in two
weeks you could isolate the virus using electro n microscopy or antibodies. It should be noted tha t if you wait a
month you get no virus; the cells all die out.
Init ially researchers were unable to isolated HTLV-III or find significant antibody titer s in healthy
homosexual males. Th is is in contrast to AIDS patients and those with the associat ed lymph node
enlar gement syndrome , of whom at least eighty percent have been found to have significant antibody titer s
(5) . Later reports, however, have found that between fifty to sixty percent (depending on the area) of healthy
homosexual males will react to HTLV-III antibody (6) . Ninety percent of hemophiliacs have antibodies to
HTLV-III. In a recent report, thi s virus was isolat ed from the semen, blood, and saliva of six out of eight
healthy homosexual males (7, 8) . Although th is was a small study, if HT LV-III is the cau se of AIDS, then
the implication is tha t there are a tremend ous number of ca rriers.
Wi th th at background , let's d iscuss two areas that might indicate HTLV-III is not the AID S virus .
Firstl y, one reason to doubt HTLV-III as the virus tha t causes AIDS is that up until April 1984, attempts to
infect chimpanze es with the AIDS virus had been unsuccessfu l. Although these chimps did not develop
AIDS, they did develop a decrease in the T-4 to T-8 ra tio, which isn' t diagnostic. Su nlight will do the same to
that rati o. One of the chimps developed a transient lymph node enlargement. The y all developed antibodies
to the HT LV-III virus. Now, more than a yea r-and-a -ha lf later, it has not been possible to produce an AIDS
like syndrome in chimps, despite injectin g them with HTLV-III from an infected cell line. Th ere is a disease
termed simian AIDS, but this is only transmissible from ape to ape. To date, it has not been shown that
hum an AIDS can be tran sferred to chimps.
Seco ndly, if you activate T-4 (helpe r) and T-8 (killer) cells in the peripheral blood, then only a small
percent age of T-4 cells will become infected upon exposu re to HT LV-II I. Over the past year, however , we
have shown tha t T-8 cells a re defective in AIDS pati ents, perhaps just as defect ive as T-4 even though they
ar e not infected (9) .
Another point that is important is that you can isolate man y viruses from the AIDS and AR C groups
we've been discussing. This should foster a healthy skepticism. For example, CMV can be isola ted with
roughl y the same frequency as HTLV-III in health y gay men, lymph node enlargement syndro me, and
pati ent s with AIDS. The same is true for Epstein-Barr virus and many kinds of herpes viruses, as well as the
antibody for hepat itis B virus.
To my knowledge, no one has tried to infect activa ted T-4 and T-8 cells with other viruses, for exa mple,
CM V and hepat itis B virus. Nei ther have other types of cells, for exam ple, smooth muscle or heart cells, been
ac tivat ed and then infected with HTLV-III to see what would happ en.
I think there is enough evidence for us to be suspicious that HT LV-III might not be the virus. I'm not
say ing that HTLV-III isn't the virus . Ma ybe it is. But we need more evidence to be sure.
A treatment that we have been trying here for AIDS patients is lymphocyte transfusions. In our
exper ience, if these infusions are given once a month they seem to prolong the lives of AIDS patients who
have received them. Our first patient in th is program , who received his first infusion over two years ago, just
died from a CNS lymphoma. He did not die from a recurrent infectio n. None of the patie nts we've transfused
have had recurrences of their infect ions.
We ca n only begin to speculate on the mind-bod y connection and how this may influence AIDS. We
know tha t in the pat ient present ed here today that his moth er had died in the recent past. Did this make his
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immune system more susceptible to AIDS ? What ever the connect ion, we all know how impor ta nt
psychological and socia l support ca n be to AIDS pat ients. Ms. Sh indell, could you comm ent on the role of the
AIDS Task Force, please?
Beth Shindell , M .S .S.. A IDS Task Force: Thank you, Dr. Hauptman. I would like to talk to you about the
role of the AIDS Task Force here in Philade lphia. Our orga niza tion was founded by a small group of gay
profe ssionals about two yea rs ago . We have grown to an orga niza tion of several hundred members that is
able to provide a var iety of services.
Our orga niza tion has severa l roles . One of our funct ions is to provide service management for people
with AIDS. That mean s that we have a group of social worker s who will-s-only on referral-see what the
patient needs. We have buddie s who will provide dire ct services, for example, grocery shopping. We also have
clinical psychologists, psychiatric social workers, and psychiatrists on our sta ff who provide direc t clinical
ca re to persons with A IDS . We have ju st sta rted two support gro ups, one for persons with AIDS and one for
their friends and families.
Another importa nt role of the AIDS Task Force is in educating the professional and lay comm unity
about AIDS. We have a resea rch comm ittee tha t keeps abreas t of the latest A IDS research, as well as an
advocacy commi ttee that seeks to address the severe forms of discr imination that may be direc ted against
persons with AIDS. For example, at the present time there is no nur sing home in the city of Philadelphia that
will accept someone with AIDS. Finally, we have a small fund, the John Locke Memorial Pa tient Support
Fund , that can be used for persons with AIDS who are in dire need of financial assista nce for housing and
clothing, transport ation, or other needs .
I am glad to be a part of thi s conference. Unfortuna tely ther e are some hospitals where our presence is
not welcome . This may derive from a misconception th at our orga niza tion is not professional in nat ure. Qu ite
the contrary is tru e. Indeed , our continued success depends upon the dedicati on of outstand ing professionals
like Dr . 11ft.
I would like to discuss briefly the impact of AIDS upon the gay community , which is the lar gest risk
group. First of all, the gay community is approximately half men and women. Gay women are not in the risk
group, unless they are sexual partners with bisexual men or are IV drug abusers.
The impact of AIDS on the gay community has been tr emendous. AIDS impact s people who are in the
prime of their life and face the loss of the ir jobs, health benefits, a nd lives. Man y profound emotions are
stirred whenever there is a loss within the Task Force or the community . Because of this, AIDS has to some
extent acted as a cohesive force in pulling the gay community togeth er .
One of the few positive outcomes of this disease may be the desensiti zat ion of the larger communi ty to
their gay neighbors . There are people who are using the term homosexual and gay who never would have
before .
If a nyone would like furth er information about the AIDS Task Force, we have several brochures
avai lable, as well as an AIDS Hotl ine, 215-232-8055 . Our address if you would like to write is: Th e
Philadelphia AIDS Task Force , P.O. Box 7259, Philadelphia, PA 19101.
Jean Helz, M .D., Assistant Director, Division oj Consultation and Liaison Psychiatry: Thank you, Ms.
Sh indell. The psychiatric concomitants of th is disease are very important. Wh enever you have an illness
that's seen as universally fat al occurring in young people who are abo ut the same age as the ir health ca re
givers , a lot of conflictua l feelings arise. I think that one importa nt and potentially dangerous man ifestat ion
of th is is deni al among health car e givers. We were ca lled to see a pat ient who complained of headaches. His
prim ar y care taker s felt that his headache s were psychosomat ic based on his impend ing dischar ge home, The
patient was an AIDS victim who was severel y ill. His head ache had no psychosomat ic features whatsoever.
After we left the room, the patient had a grand mal seizure. As it turned out, this pat ient had a eNS
cryptococcal infection.
Sever al factors may have gone into th is patient's physician's inability to recognize tha t his complaints of
headaches were related to true physical disease. Part of it was a wish th at his symptoms would be
psychosomatic so that he could go home. In other words, the physician did not wan t to believe that the patient
was as ill as he reall y was.
Another important issue is the inability of some physicians to even communicate the diagnosi s of AIDS
to the ir patients. This is an issue that a lso arises in the treatment of some ca ncer pat ients.
Dr. Haup tman : There is a study that was done in which two groups of pati ents were and were not told of their
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diagnosis of ca ncer ( 10). Wh at they found was that the pat ients who had been told th at they had cancer lived
significantly longer than the group of patients who did not know.
Dr. He/z: In practice, we often suggest that eac h patie nt's physician follow the hint s that thei r patients give
them. There are patients who do not wan t to know their diagnosis and will block out whatever you tell them.
How do you deal with telling an AIDS pati ent that they have AIDS? Is there an y hope tha t you can offer
them ?
Ms. S hindell: Isn't the matter of the pa tient knowing his own diagnosis compli cat ed by the amount of
education th at has taken place amo ng high risk groups? I mea n, I am surprised that in the case presented
th at the patient did not know that Pneumocystis carinii is indicative of A IDS.
Dr. Hauptman: No, I'm not sure tha t they get the details . A lot of my patients a re very bright and aware, but
do not know any particular s about the disease, for exa mple, Pneumocystis carinii. A lot of th is information
may be bur ied because of the tremend ous amount of information that is avai lable .
Dr. Ball: Wh at about the atti tude of hospita l staff towards ta king ca re of pa tients with AIDS? What is that
like?
Dr. Murph ey: Sta ff att itude is much better than it was when we got our first few patients. There used to be a
lot of par anoia and panic. It var ies from floor to floor and unit to unit.
Ms. S hindell: People who will ca re for an AIDS patient in the hospital will be reluctant to car e for them at
home, perh aps because they feel there is less control over the disea se a t home. In my experience, the first time
anyone comes into conta ct with an actual case of AIDS they often experience feeling s of pan ic.
Dr. Ball: Wh at was it that changed the attitude of the staff towards patient s with A IDS ?
Dr. Hauptman: The hospital administra tion asked Dr. Murph ey, myself, and two or three other people to
educa te and desensit ize hospital staff, including everyone from housekeeping staff to resident s.
Dr. Ball: Wh at is the life expecta ncy of someone with AIDS?
Dr. Hauptman: In Philadelphia, two months. Eight y-five to ninety percent of patients a re dead within six
months in the met ropolita n Philadelph ia area.
Dr. Murphey: Wh at happ ens with these patients is that the y get one opportunistic infect ion afte r another on
top of another. Pat ients who are not dead af ter two months tend to have prolonged , difficult hospital courses.
Th e pat ient ment ioned who had cryptococcal meningitis is an example . He was in th e hospit al for all but a
couple weeks of the last seven months of his life. Our first case was in the hospital for four months. Our
second case was in the hospital for the better part of three months before he died . If a pat ient has to be
hospital ized sixty days, his or her hospital costs may be as much as one million dollars . AIDS is a devastating
disease, not only to the pa tient and his family, but a lso the heal th care system as a whole, which is one good
argument for direc ting our resea rch efforts agai nst this disea se.
Dr. He/z: From a liaison psychia try sta ndpoi nt, it is clea r that AIDS is a disease that stresses every level of
the health ca re syste m. In university hospita ls I thi nk it is very import ant that these patie nts have a primar y
physician who coordina tes health ca re efforts . Often pa tient s can feel lost amid the myriad of consulta nts
who may be work ing on th ese often very difficult cases . It is very important in these cases for the pat ient to
have one physician who he can ident ify with .
Another serious issue is the homophobia th at exists among some treating physicians. We can only hope
to ide nti fy th is on an individua l basis and gra dua lly convince these physicians that their a ttit ude may
com promise the pat ient' s health ca re. Confe rences such as thi s are useful in providing for an optimal level of
exchange among physicians and health ca re worke rs.
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